Quantitative evaluation of the performance of a new test bolus-based computed tomographic angiography contrast-enhancement-prediction algorithm
Language English Country United States Media print
Document type Evaluation Study, Journal Article
- MeSH
- Algorithms * MeSH
- Adult MeSH
- Iopamidol analogs & derivatives MeSH
- Contrast Media * MeSH
- Coronary Angiography methods MeSH
- Middle Aged MeSH
- Humans MeSH
- Coronary Artery Disease diagnostic imaging MeSH
- Tomography, X-Ray Computed methods MeSH
- Image Processing, Computer-Assisted methods MeSH
- Predictive Value of Tests MeSH
- Reproducibility of Results MeSH
- Retrospective Studies MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Radiographic Image Enhancement methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Evaluation Study MeSH
- Names of Substances
- iomeprol MeSH Browser
- Iopamidol MeSH
- Contrast Media * MeSH
OBJECTIVES: The objective of this study was to assess the robustness of a novel test bolus (TB)-based computed tomographic angiography (CTA) contrast-enhancement-prediction (CEP) algorithm by retrospectively quantifying the systematic and random errors between the predicted and true enhancements. MATERIALS AND METHODS: All local institutional review boards approved this retrospective study, in which a total of 72 (3 × 24) anonymized cardiac CTA examinations were collected from 3 hospitals. All patients (46 men; median age, 62 years [range, 31-81 years]) underwent a TB scan and a cardiac CTA according to local scan and injection protocols. For each patient, a shorter TB signal and TB signals with lower temporal resolution were derived from the original TB signal. The CEP algorithm predicted the enhancement in the descending aorta (DAo) on the basis of the TB signals in the DAo, the injection protocols and kilovolt settings, as well as population-averaged blood circulation characteristics. The true enhancement was extracted with a region of interest along the DAo centerline. For each patient, the errors in timing and amplitude were calculated; differences between the hospitals were assessed using the 1-way analysis of variance (P < 0.05) and variations between the TB signals were assessed using the within-subject standard deviation. RESULTS: No significant differences were found between the 3 hospitals for any of the TB signals. With errors in the amplitude and timing of 0.3% ± 15.6% and -0.2 ± 2.0 seconds, respectively, no clinically relevant systematic errors existed. Shorter- and coarser-time-sampled TB signals introduced a within-subject standard deviation of 4.0% and 0.5 seconds, respectively. CONCLUSIONS: This TB-based CEP algorithm has no systematic errors in the timing and amplitude of predicted enhancements and is robust against coarser-time-sampled and incomplete TB scans.
References provided by Crossref.org